BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 28267771)

  • 1. Challenges in pancreatic adenocarcinoma surgery - National survey and current practice guidelines.
    Dhayat SA; Mirgorod P; Lenschow C; Senninger N; Anthoni C; Vowinkel T
    PLoS One; 2017; 12(3):e0173374. PubMed ID: 28267771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical treatment concepts for patients with pancreatic cancer in Germany--results from a national survey conducted among members of the "Chirurgische Arbeitsgemeinschaft Onkologie" (CAO) and the "Arbeitsgemeinschaft Internistische Onkologie" (AIO) of the Germany Cancer Society (DKG).
    Sargent M; Boeck S; Heinemann V; Jauch KW; Seufferlein T; Bruns CJ
    Langenbecks Arch Surg; 2011 Feb; 396(2):223-9. PubMed ID: 20711737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Borderline resectable pancreatic cancer.
    Hackert T; Ulrich A; Büchler MW
    Cancer Lett; 2016 Jun; 375(2):231-237. PubMed ID: 26970276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: Part I, AJCC staging system, NCCN guidelines, and borderline resectable disease.
    Kulkarni NM; Soloff EV; Tolat PP; Sangster GP; Fleming JB; Brook OR; Wang ZJ; Hecht EM; Zins M; Bhosale PR; Arif-Tiwari H; Mannelli L; Kambadakone AR; Tamm EP
    Abdom Radiol (NY); 2020 Mar; 45(3):716-728. PubMed ID: 31748823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance after resection of pancreatic ductal adenocarcinoma with curative intent - a multicenter survey in Germany and review of the literature.
    Ettrich TJ; Schulte LA; Eitel N; Ettrich K; Berger AW; Perkhofer L; Seufferlein T
    Z Gastroenterol; 2017 Jul; 55(7):657-666. PubMed ID: 28437802
    [No Abstract]   [Full Text] [Related]  

  • 6. Staging of pancreatic cancer: resectable, borderline resectable, and unresectable disease.
    Soloff EV; Zaheer A; Meier J; Zins M; Tamm EP
    Abdom Radiol (NY); 2018 Feb; 43(2):301-313. PubMed ID: 29198002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Indications for Surgery in Pancreatic Ductal Adenocarcinoma - Consensus Recommendations by the German Society for General and Visceral Surgery].
    Belyaev O; Bösch F; Brunner M; Müller-Debus CF; Radulova-Mauersberger O; Wellner UF; Grützmann R; Keck T; Werner J; Witzigmann H; Uhl W
    Zentralbl Chir; 2020 Aug; 145(4):354-364. PubMed ID: 32615624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection?
    Konstantinidis IT; Warshaw AL; Allen JN; Blaszkowsky LS; Castillo CF; Deshpande V; Hong TS; Kwak EL; Lauwers GY; Ryan DP; Wargo JA; Lillemoe KD; Ferrone CR
    Ann Surg; 2013 Apr; 257(4):731-6. PubMed ID: 22968073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applicability of current NCCN Guidelines for pancreatic adenocarcinoma resectability: analysis and pitfalls.
    Garces-Descovich A; Beker K; Jaramillo-Cardoso A; James Moser A; Mortele KJ
    Abdom Radiol (NY); 2018 Feb; 43(2):314-322. PubMed ID: 29392370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modified National Comprehensive Cancer Network Criteria for Assessing Resectability of Pancreatic Ductal Adenocarcinoma.
    Noda Y; Goshima S; Kawada H; Kawai N; Miyoshi T; Matsuo M; Bae KT
    AJR Am J Roentgenol; 2018 Jun; 210(6):1252-1258. PubMed ID: 29629801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Surgery for pancreatic cancer].
    Welsch T; Büchler MW; Schmidt J
    Z Gastroenterol; 2008 Dec; 46(12):1393-403. PubMed ID: 19053009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic influence of intrapancreatic tumor location on survival after resection of pancreatic ductal adenocarcinoma.
    Ruess DA; Makowiec F; Chikhladze S; Sick O; Riediger H; Hopt UT; Wittel UA
    BMC Surg; 2015 Nov; 15():123. PubMed ID: 26615588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncological outcome of laparoscopically assisted pancreatoduodenectomy for ductal adenocarcinoma in a retrospective cohort study.
    Kuesters S; Chikhladze S; Makowiec F; Sick O; Fichtner-Feigl S; Hopt UT; Wittel UA
    Int J Surg; 2018 Jul; 55():162-166. PubMed ID: 29807171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative evaluation of pancreatic ductal adenocarcinoma with synchronous liver metastasis: Diagnosis and assessment of unresectability.
    Shi HJ; Jin C; Fu DL
    World J Gastroenterol; 2016 Dec; 22(45):10024-10037. PubMed ID: 28018110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended pancreatoduodenectomy as defined by the International Study Group for Pancreatic Surgery is associated with worse survival but not with increased morbidity.
    De Reuver PR; Mittal A; Neale M; Gill AJ; Samra JS
    Surgery; 2015 Jul; 158(1):183-90. PubMed ID: 25920909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resectability After First-Line FOLFIRINOX in Initially Unresectable Locally Advanced Pancreatic Cancer: A Single-Center Experience.
    Nitsche U; Wenzel P; Siveke JT; Braren R; Holzapfel K; Schlitter AM; Stöß C; Kong B; Esposito I; Erkan M; Michalski CW; Friess H; Kleeff J
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1212-20. PubMed ID: 26350368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contemporary strategies to improve the outcome in locally advanced pancreatic cancer.
    Schneider R; Späth C; Nitsche U; Erkan M; Kleeff J
    Minerva Chir; 2017 Oct; 72(5):424-431. PubMed ID: 28565894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. R1 resection in pancreatic cancer has significant impact on long-term outcome in standardized pathology modified for routine use.
    Rau BM; Moritz K; Schuschan S; Alsfasser G; Prall F; Klar E
    Surgery; 2012 Sep; 152(3 Suppl 1):S103-11. PubMed ID: 22766366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Short- and long-term results in operable pancreatic ductal adenocarcinomas from a cooperation between two departments gastroenterology-visceral surgery at non-university hospitals benchmarked to results of expert-centers].
    Dippold W; Sivanathan V; Statt K; Roitman M; Link KH
    Z Gastroenterol; 2017 Feb; 55(2):140-144. PubMed ID: 27875849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Most pancreatic cancer resections are R1 resections.
    Esposito I; Kleeff J; Bergmann F; Reiser C; Herpel E; Friess H; Schirmacher P; Büchler MW
    Ann Surg Oncol; 2008 Jun; 15(6):1651-60. PubMed ID: 18351300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.